⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Novo Nordisk (Inferred from domain misspelling) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Novo Nordisk (Inferred from domain misspelling)
↗Bagsværd, Denmark
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Bagsværd, Denmark. The company is primarily focused on driving change to defeat diabetes and other serious chronic diseases, including obesity, rare blood disorders, and endocrine disorders.
With a massive global footprint, the company is renowned for its insulin production and breakthrough GLP-1 receptor agonist therapies like semaglutide (marketed as Ozempic, Wegovy, and Rybelsus). It is one of Europe's most valuable corporations by market capitalization and operates in over 168 countries.
CLASSIFICATION
SIZE & FINANCIALS
Employees:10000+
Revenue:$40B+
Founded:1923
Ownership:public
Status:operating
FUNDING
Investors:Novo Holdings A/S
STOCK
Exchange:NASDAQ Copenhagen, NYSE
Ticker:NOVO B (CPH), NVO (NYSE)
Market Cap:$500B+
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Peptide therapeutics, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various academic and clinical research institutions globally
COMPETITION
Position:Leader
Competitors:Eli Lilly, Sanofi, AstraZeneca, Merck
LEADERSHIP
Key Executives:
Maziar Mike Doustdar - President and CEO
LINKS
Website:novonordiak.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Novo Nordisk (Inferred from domain misspelling). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.